Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 16.1% in the morning session after the company reported ...

Myriad Genetics, Inc. MYGN reported fourth-quarter 2024 adjusted earnings of 3 cents per share, which came in line with the ...

Masimirembwa, a Distinguished Professor at Wits University's Sydney Brenner Institute for Molecular Bioscience (SBIMB), ...

U.S. Pharmacogenomics Market Growth 2025 Pharmacogenomics, also known as pharmacogenetics, is a branch of genomic medicine that uses a pati ...

The key findings from the survey stated that only half of participants knew that variations in DNA can predict either ...

Canada’s pharmaceutical industry is undergoing a major transition towards personalized medicine, which customizes therapies ...

Pharmacogenomics – an individual's genetic response to medications – is an increasingly important strand of personalised healthcare but little is known about the public's views on it.

Biochemist working with microscope Pharmacogenomics – an individual's genetic response to medications – is an increasingly ...

New research shows almost 90% of people in England would agree to genetic testing to get the most effective medication and ...

Pharmacogenomics – an individual's genetic response to medications – is an increasingly important strand of personalised ...

Researchers will launch a randomized clinical trial to assess whether PGx-guided care helps keep patients out of the ER and ...

The University of Liverpool will lead on a project which explores the potential of pharmacogenomics – the study of how the variation of the human genome affects the efficacy and safety of medicines – ...